Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
维帕替尼是一种药理学上先进的 RET 选择性抑制剂,具有较高的中枢神经系统渗透性和对 RET 溶剂前沿突变的抑制活性
期刊:Nature Cancer
影响因子:23.5
doi:10.1038/s43018-023-00630-y
Isao Miyazaki #, Igor Odintsov #, Keiji Ishida, Allan J W Lui, Masanori Kato, Tatsuya Suzuki, Tom Zhang, Kentaro Wakayama, Renate I Kurth, Ryan Cheng, Hidenori Fujita, Lukas Delasos, Morana Vojnic, Inna Khodos, Yukari Yamada, Kota Ishizawa, Marissa S Mattar, Kaoru Funabashi, Qing Chang, Shuichi Ohku